Oct 1 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
- MITHRA SIGNS LANDMARK CONTRACT FOR ESTELLE® IN THE UNITED STATES WITH MAYNE PHARMA
- MITHRA ELIGIBLE FOR LICENSE FEES OF AT LEAST USD 295 MILLION
- MITHRA TO BE AWARDED 9.6% EQUITY STAKE ACROSS TWO TRANCHES IN MAYNE PHARMA
- POTENTIAL GROSS REVENUES IN MITHRA'S WORST-CASE SCENARIO AT A MINIMUM OF EUR 4,5 BILLION, WHICH REPRESENTS MORE THAN TWICE SIZE OF EUROPEAN DEAL
- CDMO CROSS FERTILIZATION OPPORTUNITIES FOR BOTH COMPANIES
- PARTIES WILL WORK TOGETHER ON REGULATORY SUBMISSION PLANNED BY END 2019 WITH PROJECTED COMMERCIAL LAUNCH OF ESTELLE® IN H1 2021
- Forums
- ASX - By Stock
- MYX
- News: MYX Mithra Signs Landmark Contract For Estelle® With Mayne Pharma
MYX
mayne pharma group limited
Add to My Watchlist
3.69%
!
$4.96

News: MYX Mithra Signs Landmark Contract For Estelle® With Mayne Pharma
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.96 |
Change
-0.190(3.69%) |
Mkt cap ! $401.3M |
Open | High | Low | Value | Volume |
$5.05 | $5.09 | $4.93 | $785.0K | 157.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $5.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.57 | 763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 5.210 |
1 | 64 | 5.100 |
2 | 380 | 5.000 |
1 | 3583 | 4.940 |
1 | 5000 | 4.930 |
Price($) | Vol. | No. |
---|---|---|
4.570 | 763 | 1 |
4.800 | 7 | 2 |
4.840 | 163 | 3 |
4.850 | 402 | 5 |
4.900 | 5000 | 1 |
Last trade - 15.59pm 31/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |